Jason Karlawish

speaker
1,378 appearances 5 recordings 1 series first heard Feb 2021 last heard Dec 2023

Jason Karlawish’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
No recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.

Appearances

newest first · ▶ plays the moment
I kind of see the field going in that direction.
There was a moment at the uh at the Alzheimer's meetings in Amsterdam where someone said, Look, just like we have pediatric growth curves, we need
older adult dementia curves for predicting one's risk of developing dementia and then based on that obviously intervening with these various anti amyloid drugs.
I guess my dream of reason would be
Never mind these disease labels, Alzheimer's, Alouie Body, et cetera.
Let's just embrace the pathology labels and say, look, I've got a cyanucleonopathy with amyloidopathy, but no tauopathy.
My lifetime risk given my age of developing dementia is ten percent.
I'll take the therapy to reduce my amyloid, et cetera.
I mean, I would find that conversation to be kind of a dream of reason that just addresses the core problem.
I agree.
This is the blood tests become promising because there are mo bigger cohort studies with more diversity where this tubes of blood and freezers, so we can better understand what goes on with these diseases.
I think studying the diseases with imaging is a huge resource lift, but blood allows large cohorts to be studied.
Let's be leaders in the U United States effort to tackle the problem of Alzheimer's writ large and that means being part of the biomarker transformation and delivering our great expertise in c care for the patient and their family.
Thank you so much, Ericsson.
Thank you.
Great to be back.
Alex and Eric.
Alex
The times there are changing.
Brilliant.
Showing 461–480 of 1,378 · page 24 of 69 ← Previous Next →